Endre Kasztreiner

Title: Endre Kasztreiner: Innovator in Pharmaceutical Chemistry

Introduction

Endre Kasztreiner is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 13 patents. His work primarily focuses on compounds that have therapeutic applications, particularly in treating benign prostate hyperplasia.

Latest Patents

Among his latest patents is the invention related to N-([1,4]benzodioxan-2-ylmethyl)-N-(3-chloro-1-propyl)-amine. This invention encompasses R-2-[3-([1,4]benzodioxan-2-ylmethylamino)-1-propyl]-3(2H)-pyridazinone and S-2-[3-([1,4]benzodioxan-2-ylmethylamino)-1-propyl]-3(2H)-pyridazinone, along with their acid-addition salts and pharmaceutical compositions. The compounds exhibit α- and β-adrenoceptor antagonistic effects and urogenital selectivity, making them valuable for medical treatments.

Career Highlights

Endre Kasztreiner has worked with prominent companies in the pharmaceutical industry, including Richter Gedeon Vegyeszeti Gyar Rt and Gyogyszerkutato Intezet Kft. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, Kasztreiner has collaborated with notable colleagues such as Gyorgy Cseh and Laszlo Jaszlits. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Endre Kasztreiner's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field positively, particularly in the development of treatments for benign prostate hyperplasia.